Primary Sjogren's syndrome presenting as progressive parkinsonian syndrome

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 121-123

  Creange, A ^a   Brugieres, P ^a   Voisin, M C ^a   Degos, J D ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; ELECTROMYOGRAPHY; FEMALE; GAIT DISORDER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PARKINSONISM; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; XEROSTOMIA; BRAIN; DIFFERENTIAL DIAGNOSIS; HEMISPHERIC DOMINANCE; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY;

ADULT; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; SJOGREN'S SYNDROME;

EID: 0031018159     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120124     Document Type: Article

References (17)

1. 1 Block KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological, and serological study of sixty‐two cases [Classic article]. Medicine 1992 ; 71: 386–401.
2. 2 Alexander EL. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle: a clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 1993 ; 19: 869–904.
3. 3 Tesar JT, McMillan V, Molina R, Armstrong J. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome. Am J Med 1992 ; 92: 686–92.
4. 4 Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. The spectrum of neurological involvement in Sjögren's syndrome. Br J Rheumatol 1990 ; 29: 21–23.
5. 5 Créange A, Laplane D, Baulac M, Attal N, Assuérus V. Démence révélatrice du syndrome de Gougerot‐Sjögren primitif. Rev Neurol (Paris) 1992 ; 148: 376–80.
6. 6 Bragoni M, Di Piero V, Priori R, Valesini G, Lenzi GL. Sjögren's syndrome presenting as ischemic stroke. Stroke 1994 ; 25: 2276–9.
7. 7 Visser LH, Koudstaal PJ, van de Merwe JP. Hemiparkinsonism in a patient with primary Sjögren's syndrome: a case report and a review of the literature. Clin Neurol Neurosurg 1993 ; 95: 141–5.
8. 8 Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993 ; 36: 340–7.
9. 9 Mao C, Gancher ST, Herndon RM. Movement disorders in multiple sclerosis. Mov Disord 1988 ; 3: 109–16.
10. 10 Malinow KL, Molina R, Gordon B, Selnes OA, Provost TT, Alexander EL. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med 1985 ; 103: 344–9.
11. 11 Bakchine S, Duyckaerts Ch, Hassine L, et al. Lésions neurologiques centrales et périphériques au cours d'un syndrome de Gougerot‐Sjögren primitif: etude clinicopathologique d'un cas. Rev Neurol (Paris) 1991 ; 147: 368–75.
12. 12 Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsurea T. Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjögren's syndrome‐associated cases. J Neurol 1993 ; 240: 1–7.
13. 13 Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994 ; 117: 877–97.
14. 14 Pierot L, Sauve C, Leger JM, et al. Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases. Neuroradiology 1993 ; 35: 378–80.
15. 15 Alexander EL, Beall SS, Gordon B, et al. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med 1988 ; 108: 815–23.
16. 16 Ballow M, Parke A. The uses of intravenous immune globulin in collagen vascular disorders. J Allergy Clin Immunol 1989 ; 84: 608–12.
17. 17 Moll JWB, Markusse HM, Pijnenburg JJJM, Vecht CJ, Henzen‐Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome. Neurology 1993 ; 43: 2574–81.